On 14 December 2020, Anatara Lifesciences Limited (ASX:ANR) announced details of an off-market share buy-back facility (Buy-Back Facility) to buyback all of the shares held by shareholders who held unmarketable parcels of shares in the Company.
Anatara Lifesciences (ASX:ANR) is pleased to advise that it is has received Human Research Ethics Committee (HREC) approval to undertake a clinical trial of its Gastrointestinal Re-Programming complementary medicine (GaRP) in participants with irritable bowel syndrome - diarrhoea subtype (IBS-D).
Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $888,049 from the Australian Taxation Office under the Federal Government's Research and Development (R&D) tax incentive scheme.
Anatara Lifesciences (ASX:ANR) is pleased to announce successful completion of the poultry challenge trial "Efficacy of ANR-pf on the performance of broilers subject to subclinical and necrotic enteritis challenges".
Anatara Lifesciences (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2020. The Company's cash plus term deposits at the end of the quarter stood at $3.68m.
Nyrada Inc (ASX:NYR) is pleased to report encouraging efficacy results from its cholesterol-lowering drug program which is directed at developing an oral PCSK9 inhibitor treatment for hypercholesterolemia (high cholesterol).
Anatara Lifesciences (ASX:ANR) is pleased to advise that it is planning initiation of a human clinical study on changes to psychological functioning in adults with a moderate level of depression, anxiety or stress symptoms, in response to use of the Company's recently developed colon-targeted formulation (3FDC).
Banking & Finance
- Troy Duran Interviews Dr. Eric Jensen of EMX Royalty and Ellis Martin of Martin Laboratories Optioning 5 Battery Metals Projects in Scandinavia.
- Resolution Minerals Ltd (ASX:RML) Positive Revision of JV Agreement for 64North Project Alaska
- Ellis Martin Report: EMX Royalty Corp's Dr. Eric Jensen on Contrarian Investments that Can Pay Off (NYSE:EMX)
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Quarterly Webinar Presentation
- Deep Yellow Limited (ASX:DYL) A$40.8M Placement Successfully Completed
- Central Petroleum Limited (ASX:CTP) Half Year Results - Reports $2.5 Million Net Profit
- Beroni Group Limited (NSX:BTG) Appointment of Non-Executive Director
- BPH Energy Limited (ASX:BPH) Advent Commissions Environmental Review
- Ellis Martin Report: Entheon Biomedical (CNSX:ENBI) CEO Timothy Ko on the Ethical Clinical Use of DMT for Treating Substance Abuse, Depression, Anxiety and More